<DOC>
	<DOC>NCT01257035</DOC>
	<brief_summary>The primary purpose of the study is to investigate 18F-FAZA-PETs role as predictor of response to neoadjuvant chemoradiation of locally advanced rectum cancer.</brief_summary>
	<brief_title>Predictive Value of 18F-FAZA in Rectum Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Histopatologically verified adenocarcinoma in the rectum T4 tumor eller T3 tumor &lt; 10 cm from the anus and &lt; 5 mm from the mesorectal fascie measured by MR scan. At the distal part of the rectum the distance to the mesorectal fascie is &lt; 5 mm and therefore all T3 tumors are included in this area Suitable for preoperative radiation and chemotherapy No distant metastases Age &gt;18 years Hematology ANC ≥1.5x10^9/l. Thrombocytes ≥ 100x10^9/l. Biochemistry Bilirubin ≤ 3 x UNL. ALAT ≤ 5 x UNL Creatinine ≤ UNL Contraception for fertile women Written and orally informed consent Other malignant disease within 5 years, excl. nonmelanotic skin cancer Previous radiation treatment of the pelvis Pregnant or breastfeeding women Surgery within 6 weeks prior to enrollment Serious concurrent medical disease Enrollment in study "A prospective observational study of patients with rectum cancer after concomitant radiation and chemotherapy", where the patients are potientially not operated.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Rectum cancer</keyword>
	<keyword>FAZA</keyword>
	<keyword>18F-FAZA-PET/CT</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemoradiotherapy</keyword>
</DOC>